Labeler · US market

Provepharm Inc.

Provepharm Inc. is a US drug labeler with US FDA registrations covering 6 drug concepts (6 currently active) across 14 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes81284

Active drugs6

Registrations13 active / 13

Packages14

Sole supplier of0 drugs

Portfolio6 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Piperacillin Sodium And Tazobactam Sodium injection, powder, lyophilized, for solution	rx	5	5	SUPPLYING
Phenylephrine Hydrochloride injection	rx	3	3	SUPPLYING
Tranexamic Acid injection, solution	rx	2	2	SUPPLYING
Dihydroergotamine Mesylate injection, solution	rx	1	2	SUPPLYING
Physostigmine Salicylate injection	rx	1	1	SUPPLYING
Indigotindisulfonate Sodium injection	rx	1	1	SUPPLYING

At a glance

TypeLabeler
Labeler codes81284
Filing names1
Drugs (active)6
Drugs (all time)6
US registrations13
Packages14

Recent events

Shortages, recalls, and registration changes across all filing names.

Jan 21, 2025
RECALLRecall (Class I): Phenylephrine HCl Injection, USP 100 mg/10 mL (10 mg/mL) vials, Rx only, Pharmacy Bulk Package (supplied as a single un…
Nov 22, 2024
RECALLRecall (Class II): Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.